News

Thursday March 31, 2022

Presenting data at the ECCMID 2022 Congress

Destiny Pharma plc (“Destiny Pharma” or “the Company”) Data on the antimicrobial activity of XF-73 against bacteria within biofilms to be presented at prestigious 2022 ECCMID Congress Brighton, United Kingdom – […]

Monday March 28, 2022

Result of General Meeting and Total Voting Rights

THIS ANNOUNCEMENT (INCLUDING THE APPENDIX) AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO […]

Friday March 25, 2022

Destiny’s microbiome project article published in Vantage

Destiny Pharma’s CEO, Neil Clark, discusses the Company’s microbiome project with Vantage. Read the full article here

Friday March 25, 2022

Result of Open Offer

THIS ANNOUNCEMENT (INCLUDING THE APPENDIX) AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO […]

Wednesday March 23, 2022

Destiny Pharma publish in the European Biopharmaceutical Review Journal “Global Ri...

Dr Bill Love, Chief Scientific Officer at Destiny Pharma, writes “The rise of antimicrobial resistance (AMR) has necessitated ongoing initiatives to offset the global threat and promote innovation, with financial […]

Tuesday March 22, 2022

Exercise of Options and Total Voting Rights

Destiny Pharma plc (“Destiny Pharma” or “the Company”) Exercise of Options and Total Voting Rights Brighton, United Kingdom – 22 March 2022 – Destiny Pharma (AIM: DEST), a clinical stage […]

Thursday March 17, 2022

Open Offer Application Form

Open Offer Application Form

Thursday March 17, 2022

Form of Proxy

17 March 2022 – Form of Proxy

Wednesday March 9, 2022

Circular to shareholders

09 March 2022 – Circular to shareholders

Tuesday March 8, 2022

Fundraising

THIS ANNOUNCEMENT (INCLUDING THE APPENDICES) (THIS “ANNOUNCEMENT”) AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, […]